{"cord_uid":"ryzpy3nw", "sourcedb":"PMC", "sourceid":"PMC3433334", "divid":13, "text":"The primary efficacy variable was the p27 antigen analysis of serum samples. According to the Monograph 01/2005:1321 Feline Leukaemia Vaccine (Inactivated) only summaries of the data need be presented in terms of the number and percentage of animals with persistent antigenaemia (as determined by p27 protein), by treatment group. Persistent antigenaemia for an animal was defined (as per Pharmacopoeia) as being when an animal was positive for the p27 antigen for three consecutive weeks or on five separate occasions (consecutively or not) from the third week to the fifteenth week after FeLV challenge.", "project":"cdlai_CORD-19", "denotations":[]}